H. G. PALA, O. ERBAŞ, F OLTULU, E. E. PALA, H. AKTUĞ, A. YAVAŞOĞLU

Diyabetik sıçan overlerindeki glikoz hasarı ve NF-kappa B yolunun etkisi

Amaç: Bu çalışmada, sıçan modellerinde glikoz toksisitesinin overdeki hasarlanma şiddeti ve bu hasarın NF-kappa B üzerinden etkilerinin olup olmadığının araştırılması amaçlandı. Gereç ve Yöntem: Yedi adet sıçanda deneysel olarak diyabetes mellitus modeli oluşturuldu. Yedi adet kan glikoz seviyesi normal olan sıçan kontrol grubu olarak alındı. Sekiz hafta sonra over dokuları çıkarılıp histolojik olarak incelendi. Grupların özellikleri, tek yönlü ANOVA ve Mann Whitney U testi ile karşılaştırıldı. p

Glucose injury in diabetic rats' ovaries and effect of NF-kappa B way

Aim: To investigate glucose toxicity for ovarian damage severity and the effect of these by NF-kappa B way in rat models. Materials and Methods: An experimental diabetes mellitus model was created in seven rats. All seven rats, whose blood glucose levels were normal, were included in the control group. After eight weeks; bilateral oophorectomy was performed and the ovaries were researched histologically. The group characteristics were compared by one-way ANOVA and Mann Whitney U test. p values less than 0.05 were accepted as significant. Results: There was a significant increase of follicular degeneration, stromal degeneration, stromal fibrosis and NF-kappa B immune-expression in diabetic rats' ovary when compared to the control group of normal rats (p=0,0001). Conclusion: Our study shows that glucose toxicity occured severely in the ovaries and this injury originated in the NF-kappa B way in diabetes mellitus. Therefore, NF-kappa B inhibitors continue to be promising in preventing diabetic related tissue injury.

PDF

___

1) Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107(9):1058-70.
2) Brownlee M. The pathobiology of diabetic complications: An unifying mechanism. Diabetes 2005;54(6):1615-25.
3) Yan SF, Ramasamy R, Schmidt AM. Mechanisms of Disease: Advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 2008;4(5):285-93.
4) Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 2007;82(2):204-12.
5) Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006;114(6):597-605.
6) Yao D, Taguchi T, Matsumura T, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007;282(42):31038-45.
7) Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor beta1 production is mediated by hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 1998;101(1):160-9.
8) Queisser MA, Yao D, Geisler S, et al. Hyperglycemia impairs proteasome function by methylglyoxal. 2010;59(3):670-8.
9) Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000;106(4):571-8.
10) Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007;117(5):1249-59.
11) Pitkanen OM, Martin JM, Hallman M, Akerblom HK, Sariola H, Andersson SM. Free radical activity during development of insulin dependent diabetes mellitus in the rat. Life Sci 1992;50(5):335-9.
12) Gillery P, Monboisse JC, Maquart FX, Borel JP. Glycation of proteins as a source of superoxide. Diabetes 1988;14(1):1114-20.
13) Dinçer Y, Akçay T, Alademir Z, İlkova H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002;51(10):1360-2.
14) Eidland A, Sebekova K, Schinzel R. Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 2001;38 (4):100-6.
15) Giardino I, Edelstein D, Brownlee M. Bcl-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation end products in bovine endothelial cells. J Clin Invest 1996;97(6):1422-8.
16) Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabet Med 2001;18(12):945-59.
17) Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol Biol (Paris) 2006;54(7):405-19.
18) Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 2005;38(2):103-15.
19) Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J Biochem Mol Biol 2005;38(5):539-44.
20) Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67(4):604-6.
21) Sinha P, Kuruba N. Premature ovarian failure. J Obstet Gynaecol 2007;27(1):16-9.